honors

IRP’s Bruce Tromberg Elected to National Academy of Medicine

Advances in Bioengineering Drive Life-Saving Medicine

Dr. Bruce Tromberg

“To discover new things, you need new ways to see them,” says Bruce J. Tromberg, Ph.D., Director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). That’s why he has spent the past 30 years of his career improving and inventing tools to help doctors and scientists conduct cutting-edge biomedical research and apply their findings to the task of saving lives. This past October, Dr. Tromberg was elected to the National Academy of Medicine (NAM) for his contributions to the fields of biophotonics and biomedical optics, as well as his leadership in the biomedical engineering and imaging community.

IRP’s Eugene Koonin Elected to National Academy of Medicine

Scientist Decoded DNA to Build a Genomic Tree of Life

Dr. Eugene Koonin

In 1973, the geneticist Theodosius Dobzhansky wrote a now-famous essay that declared, “Nothing in biology makes sense except in the light of evolution.” That sentiment has served as the guiding principle for the career of IRP senior investigator Eugene V. Koonin, Ph.D., who was elected to the National Academy of Medicine (NAM) in October 2022 for his contributions to the field of evolutionary biology.

Dr. Koonin’s pioneering efforts to identify clusters of similar genes found in different organisms passed down by a common ancestor — known as ‘homologous’ genes — has helped to unlock the secrets encoded in DNA and create a foundation for the systematic study of how genes evolve and function. His lab at the National Library of Medicine’s National Center for Biotechnology Information (NCBI) uses a combination of genomic sequencing and mathematical modeling to compare genes across species and determine how they work and where they came from. From this information, his team can develop a systematic framework to show the relationship between genes as they evolved. It’s like drawing the tree of life, but on a genomic scale.

Research Helps Guide Families Safely Through Pandemic

IRP’s Diana Bianchi Honored for Leading Pediatric COVID Response

Dr. Diana Bianchi

When the first reports of COVID-19 came out, infectious disease experts and healthcare providers thought children might be spared its most dire effects. After all, the news reports and health statistics showed that nearly all serious cases occurred in the elderly, people with certain pre-existing conditions, and those who spent their days and nights caring for COVID patients. However, as case counts rose and disruptions in daily life grew, the medical and psychological effects of COVID on children became apparent — and the impact was alarming. It soon became clear that something had to be done to understand the disease's effects on infants, children and teens, as well as pregnant women and traditionally underserved communities.

It was, appropriately, Mother’s Day when then-NIH Director Francis Collins sought help from Diana W. Bianchi, M.D., Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and a senior investigator in the National Human Genome Research Institute (NHGRI). An expert in infant health and genetic conditions like Down syndrome, Dr. Bianchi was just the person to initiate large-scale studies across the country to assess the severity of COVID in specific populations, the safety and efficacy of vaccination and treatment, and the impact of mitigation efforts such as masking. For this critical leadership, Dr. Bianchi was named a finalist for the 2022 Samuel J. Heyman Service to America Medal for COVID-19 Response.

Understanding the Foundations of Immune Defenses

IRP’s Mary Carrington Elected to the American Academy of Arts and Sciences for Insights Into Immune System Variations

Dr. Mary Carrington

Some people never seem to get sick, while others catch a new bug of some sort every other week. Humans are immensely variable both in their capacity to shrug off illness and in the ways their bodies respond to medical treatments. IRP senior investigator Mary Carrington, Ph.D., has spent her entire career exploring the biological roots of these differences, and the discoveries she has made earned her election to the American Academy of Arts and Sciences earlier this year.

Leading the Charge Against Infectious Disease

Government Awards Recognize H. Clifford Lane’s Four Decades of Research Achievements

Dr. H. Clifford Lane

The remarkable career of H. Clifford Lane, M.D., might have gone very differently if a NIH scientist hadn’t accidentally eavesdropped on Dr. Lane’s conversation with a colleague in 1979. After hearing Dr. Lane mention that he had missed the deadline to apply for a position at NIH, the NIH researcher made some calls and discovered a spot there had just opened up — one that was perfect for Dr. Lane, who would spend the ensuing decades conducting life-saving research to understand and combat some of the world’s most dangerous infectious diseases.

Now the Clinical Director at the National Institute for Allergy and Infectious Disease (NIAID), Dr. Lane has been named a finalist for the 2022 Samuel J. Heyman Service to America Medals’ Career Achievement Award in recognition of his crucial contributions to the fight against HIV/AIDS, Ebola, COVID-19, and other illnesses. Also known as the “Sammies,” the awards recognize federal employees who are “breaking down barriers, overcoming huge challenges, and getting results.”

IRP’s Shannon Zenk Elected to the National Academy of Medicine

Nursing Research Leader Sheds Light on How Neighborhoods Influence Health

Dr. Shannon Zenk

When you think about public health, city planning might not be the first thing that comes to mind. Yet where we live — the quality of the buildings, the availability of places to walk and play safely, and the types of schools and stores in the neighborhood — can profoundly affect our health. This relationship has been emphasized by the COVID-19 pandemic, as close, stuffy living conditions, the need to take public transportation to essential jobs, and inequities in access to testing and vaccination sites all contributed to the larger reduction in life expectancy for Black and Latino Americans compared to Caucasians over the last two years.

Shannon N. Zenk, Ph.D., M.P.H., R.N., F.A.A.N., Director of the National Institute of Nursing Research (NINR), was elected to the National Academy of Medicine in 2021 for her research into how neighborhood characteristics affect the health of residents and contribute to the health disparities seen between communities with different racial and ethnic makeups and different levels of income.

IRP’s Steven Rosenberg Receives HHS Secretary’s Award for Distinguished Service

Groundbreaking Immunotherapy Research Revolutionizes Cancer Treatment

Dr. Steven Rosenberg

Like many young boys, IRP senior investigator Steven A. Rosenberg, M.D., Ph.D., initially believed he would grow up to become a cowboy, a dream he shared with his older brother, Jerry. That plan changed after World War II ended and stories began coming out of Europe about members of his family who had perished in concentration camps.

“I just became so upset about the evil that people could perpetrate on one another,” he recalls. “Right then and there, I knew I wanted to do the opposite. I wanted to do things that would help people, and I developed almost a spiritual desire to become a doctor.”

He ultimately did become a doctor, and his pioneering research into how cancer interacts with the immune system has led to treatments that are reducing suffering for many people with cancer. In recognition of this groundbreaking work, Dr. Rosenberg was awarded the HHS Secretary’s Award for Distinguished Service in August 2021. The highest honor given by the US Department of Health and Human Services (HHS), the award celebrates excellence in leadership, ability, and service.

Breakthrough Treatment Brings Hope to Children with Tumor Disorder

Brigitte Widemann Recognized for Pioneering Work on Debilitating Disease

Dr. Brigitte C. Widemann

Getting diagnosed with a serious illness as an adult can be devastating, so one can hardly imagine the impact of receiving such news as a child, particularly when the disease has no good treatments. Until recently, this was the case for many children with the potentially severe and frequently disfiguring condition neurofibromatosis type 1 (NF1). However, pioneering research led by IRP senior investigator Brigitte C. Widemann, M.D., led to the first-ever drug approved by the U.S. Food and Drug Administration (FDA) to treat the condition. For this groundbreaking work, Dr. Widemann, her IRP research team, and her collaborators outside NIH were named as finalists for the 2020 Samuel J. Heyman Service to America Medals, also known as the ‘Sammies,’ an award that honors exceptional work by government employees.

A Record-Breaking Sprint to Create a COVID-19 Vaccine

Kizzmekia Corbett and Barney Graham Recognized for Leading IRP Vaccine Research

Dr. Kizzmekia Corbett (left) and Dr. Barney Graham (right)

At the end of 2019, most people were planning for a typical busy year in 2020. The world was looking forward to the Summer Olympics in Japan, the U.S. was deep into election campaigns, and IRP scientists at NIH’s Vaccine Research Center (VRC) were designing vaccines for several coronaviruses in collaboration with a small biotech company called Moderna.

That all changed on a Saturday morning in early January. Chinese scientists had isolated a new coronavirus that was causing a serious epidemic in China’s Wuhan province and released its genetic sequence to the scientific community around the world. Barney Graham, M.D., Ph.D., director of the VRC’s Viral Pathogenesis Laboratory (VPL), and VRC research fellow Kizzmekia Corbett, Ph.D., dropped everything and immediately began working on a vaccine for the illness that would become known as COVID-19.

IRP’s Charles Rotimi Elected to American Academy of Arts and Sciences

Pioneering Genetic Epidemiologist Takes a Global Approach to Fighting Health Disparities

Dr. Charles Rotimi

IRP distinguished investigator Charles Rotimi, Ph.D., was elected to the American Academy of Arts and Sciences this year in recognition of his pioneering work exploring the health implications of genetic diversity in populations with African ancestry, as well as for globalizing the study of genomics, particularly in African nations. Dr. Rotimi joined NIH in 2008 as the founding director of the Intramural Center for Genomics and Health Disparities in the National Human Genome Research Institute (NHGRI), which was later renamed the Center for Research on Genomics and Global Health, in part to reflect Dr. Rotimi’s globe-spanning research programs.